Search results
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 32 minutes agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 25 minutes agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 35 minutes agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks· 13 hours agoModerna (MRNA) beats expectations for both earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 8 hours agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 1 hour agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoImage source: The Motley Fool. Moderna (NASDAQ: MRNA) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 8 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall
Investing.com· 13 hours agoModerna Inc. (NASDAQ: MRNA ) reported first-quarter earnings and revenue that came ahead of analyst...